Nordea Investment Management AB, a leading investment management company, has recently made headlines by trimming its position in Apollo Medical Holdings, Inc. (NASDAQ: AMEH). According to its latest filing with the Securities and Exchange Commission (SEC) for the second quarter of this year, Nordea Investment Management AB reduced its holdings in the company by 30.2%. The fund now owns 68,823 shares of Apollo Medical’s stock after selling 29,771 shares during the specified period. As of the filing date, these shares were valued at approximately $2,256,000.
Apollo Medical is a healthcare services provider that operates in various regions across the United States. The company offers innovative medical solutions and technologies aimed at improving patient care and outcomes. Its comprehensive range of services includes hospitalist programs, clinical laboratory testing, specialty pharmacy services, and care coordination.
In related news, Apollo Medical recently announced its quarterly earnings results on August 7th. For the quarter, the company reported earnings per share (EPS) of $0.28 – matching analysts’ consensus estimates precisely. This figure reflects the profitability of a company by indicating its net income attributable to each share of common stock outstanding.
Additionally, Apollo Medical achieved a return on equity (ROE) of 11% during this period. ROE is a measure used to assess how effectively a company generates profit using shareholders’ investments. A higher ROE indicates efficient utilization of capital.
The firm also showcased an impressive net margin of 3.95%, emphasizing its ability to convert revenue into profits after accounting for expenses and other costs associated with operations.
Apollo Medical generated revenues amounting to $348.21 million throughout the quarter under review – surpassing market expectations set at $341.10 million as per industry analysts’ consensus estimates. Remarkably strong revenue figures serve as indicators for business growth and market demand for a company’s products or services.
Looking ahead, industry analysts anticipate that Apollo Medical Holdings, Inc. is expected to post earnings per share of 1.11 for the current fiscal year. The EPS projection provides insight into a company’s profitability and potential future performance.
Nordea Investment Management AB’s decision to reduce its position in Apollo Medical may reflect various factors, such as shifting investment strategies or a reassessment of the company’s financial performance. Nonetheless, it is imperative to note that investment decisions should be evaluated based on a comprehensive analysis of multiple factors considered by investors.
Overall, Nordea Investment Management AB’s recent trimming of its position in Apollo Medical Holdings, Inc. highlights notable developments within the healthcare services sector and reflects market dynamics that influence investment decisions.
[bs_slider_forecast ticker=”ARES”]
Significant Shifts in Holdings of Prominent Investors Impact Apollo Medical Holdings’ Stock Performance
September 24, 2023 – Apollo Medical Holdings, Inc. has recently seen a significant shift in the holdings of several prominent investors. FMR LLC, Arizona State Retirement System, Tower Research Capital LLC TRC, Mirae Asset Global Investments Co. Ltd., and PNC Financial Services Group Inc. have all made modifications to their positions in the company.
FMR LLC increased its stake in Apollo Medical by 36.1% during the second quarter. The investment firm now owns 1,067 shares of the company’s stock valued at $41,000, after acquiring an additional 283 shares over the last quarter. Similarly, Arizona State Retirement System raised its position by 3.2% during the first quarter and now holds 11,505 shares worth approximately $420,000.
Tower Research Capital LLC TRC took a more significant leap by raising its position in Apollo Medical by 91.2% during the first quarter. The firm acquired an additional 477 shares of the company’s stock valued at $36,000. In another notable move, Mirae Asset Global Investments Co. Ltd saw a modest increase of 3.0% in their position during the first quarter and now owns 17,051 shares worth $622,000.
Finally, PNC Financial Services Group Inc., one of the largest financial institutions in the US,intensified its stake substantially by raising it to a notable extent of almost 50%. PNC Financial Services Group Inc.’s stake comprises of holding approximately1579 shares with an estimated value of $75k.
These substantial modifications made by influential investors indicate confidence or adjustments within Apollo Medical Holdings’ future prospects and performance within their respective portfolios.
Apollo Medical Holdings is listed on NASDAQ under the ticker symbol AMEH; which opened at $29.94 on Friday.With respect to its market performance,the company currently has a market capitalization value standing at almost $1.72 billion. Its price-to-earnings (P/E) ratio is 27.47, which discerns the stock’s relative value inplace of current earnings.However, an interesting aspect to consider is the low price-to-earnings growth (P/E/G) ratioof Apollo Medical Holdings which stands at 2.40 suggesting a higher degree of perplexity.
The company also holds a beta of 0.83, indicating that it has exhibited lower volatility in comparison to the overall market benchmark.
When examining liquidity measures,the company possesses a quick ratio and current ratio both standing at 2.50; demonstrating Apollo Medical Holding’s ability to meet its short-term obligations and manage its day-to-day operations with ease.
Regarding its financial structure, the company maintains a debt-to-equity ratio of 0.36. This suggests a lower proportion of debt financing as compared to equity,and hence implies potentially lower risk for investors in terms of leverage.
Apollo Medical Holdings’ stock has experienced fluctuations over the past year,with a 12-month low of$26.89 and a 12-month high reaching $42.08.In terms of moving averages,the stock currently displaysa fifty-day simple moving average amounting to $35.46 anda two hundred-day simple moving average totaling $34.86 respectively.
As institutional investors hold approximately 35.88% of the company’s shares, their actions and decisions have significant implications on the future trajectory of Apollo Medical Holdings’ stock performance.
In conclusion, Apollo Medical Holdings has witnessed substantial modifications in its holdings as various large investors have made adjustments to their positions in the company.These changes reflect either heightened confidence or strategic shifts within these investors’ portfolios.Apollo Medical Holdings’ stock opens at $29.94 on NASDAQ with commendable market capitalization.Constant monitoring is required due to perplexing P/E/G ratio along with essential factors like beta,ratios illustrating financial health,strong liquidity,and debt-to-equity composition. Investors should carefully evaluate these variables when considering the potential benefits and risks associated with investing in Apollo Medical Holdings.
